Safety and efficacy of low-dosage apatinib monotherapy in advanced lung squamous-cell carcinoma: a prospective cohort study

Q Geng, H Shen, W Zhu, Y Lu, M Wang… - OncoTargets and …, 2020 - Taylor & Francis
Background Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …
被引用次数：7 相关文章

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study.

Q Geng, H Shen, W Zhu, Y Lu, M Wang… - OncoTargets & …, 2020 - search.ebscohost.com
Background: Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study

Q Geng, H Shen, W Zhu, Y Lu, M Wang… - OncoTargets and …, 2020 - search.proquest.com
Background: Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study.

Q Geng, H Shen, W Zhu, Y Lu, M Wang… - Oncotargets and …, 2020 - europepmc.org
Background Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study

Q Geng, H Shen, W Zhu, Y Lu, M Wang… - OncoTargets and …, 2020 - dovepress.com
Background: Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …
[PDF] scienceopen.com

[PDF][PDF] Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study

Q Geng, H Shen, W Zhu, Y Lu, M Wang… - OncoTargets and …, 2020 - scienceopen.com
Background: Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …
[HTML] nih.gov

[HTML][HTML] Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study

Q Geng, H Shen, W Zhu, Y Lu, M Wang… - OncoTargets and …, 2020 - ncbi.nlm.nih.gov
Background Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …

Safety and Efficacy of Low-Dosage Apatinib Monotherapy in Advanced Lung Squamous-Cell Carcinoma: A Prospective Cohort Study

Q Geng, H Shen, W Zhu, Y Lu… - OncoTargets and …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Lung squamous-cell carcinoma (SqCC) is the second most common histology
in non-small-cell lung carcinomas (NSCLCs). The treatment options for advanced lung …